<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03461523</url>
  </required_header>
  <id_info>
    <org_study_id>BMI</org_study_id>
    <nct_id>NCT03461523</nct_id>
  </id_info>
  <brief_title>Observational, Prospective, Single-center Study: Should Body Mass Index (BMI) be Added to the Scoring Criteria of Hepatic Critically Ill Patients in Intensive Care Unit??</brief_title>
  <official_title>Observational, Prospective, Single-center Study: Should Body Mass Index (BMI) be Added to the Scoring Criteria of Hepatic Critically Ill Patients in Intensive Care Unit??</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Hepatology &amp; Tropical Medicine Research Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Hepatology &amp; Tropical Medicine Research Institute</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to evaluate the hypothesis of poor clinical outcomes in
      critically ill patients that are having abnormal BMI.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      All demographic data will be obtained including the patients' age, sex, body mass index (BMI)
      &amp; categorized into; BMI &lt; 18.5Kg/m2 = underweight, BMI between 18.5-24.9Kg/m2 = normal
      weight, while BMI between 25-29.9Kg/m2 = overweight &amp; obese = BMI ≥ 30Kg/m2, associated
      co-morbidities (diabetes mellitus, hypertension, chronic renal failure, cancer&amp; chronic liver
      disease), the cause of admission to ICU, Sequential Organ Failure Assessment (SOFA),
      nutritional risk screening (NRS) on admission &amp; discharge, prior cardiac arrest, previous ICU
      admission within 6months, nosocomial infection, organ failure e.g. cardiovascular,
      respiratory, renal &amp; organic support requirement e.g. hemodynamic support, mechanical
      ventilation, renal replacement therapy (RRT).
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 10, 2018</start_date>
  <completion_date type="Anticipated">February 2021</completion_date>
  <primary_completion_date type="Anticipated">December 2020</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>15 Days</target_duration>
  <primary_outcome>
    <measure>ICU stay</measure>
    <time_frame>average 2 - 4 weeks</time_frame>
    <description>Length of ICU stay in days</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Mortality</measure>
    <time_frame>average 2-4 weeks</time_frame>
    <description>ICU Mortality in days</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>the need for mechanical ventilation</measure>
    <time_frame>during ICU stay 2-4 weeks</time_frame>
    <description>notice &amp; register the need for &amp; type of mechanical ventilation; invasive or non invasive &amp; days of ventilation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of mechanical ventilation</measure>
    <time_frame>1-4 weeks</time_frame>
    <description>Duration in days</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>the need for pharmacological support</measure>
    <time_frame>1-4 weeks</time_frame>
    <description>notice &amp; register the need for drugs to support the hemodynamics</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>occurrence of nosocomial infection</measure>
    <time_frame>2-28 days</time_frame>
    <description>site of nosocomial infection</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospital stay</measure>
    <time_frame>average 2-28days</time_frame>
    <description>Length of hospital stay</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospital mortality</measure>
    <time_frame>average 28 days</time_frame>
    <description>mortality</description>
  </secondary_outcome>
  <enrollment type="Anticipated">500</enrollment>
  <condition>ICU Stay &amp; Mortality</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients that will be admitted to ICU will be categorized into; BMI &lt; 18.5Kg/m2
        =underweight, BMI between 18.5-24.9Kg/m2 = normal weight, while BMI between 25-29.9Kg/m2 =
        overweight &amp; obese = BMI ≥ 30Kg/m2
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients who are admitted to the intensive care unit of National Hepatology &amp; Tropical
             Medicine Research Institute (NHTMRI) for medical &amp; surgical indications during the
             period from February 2018 to December 2020.

        Exclusion Criteria:

          -  Patients will be excluded if they have stayed in ICU ≤24 hours.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Eman El-Desoki, Ph D</last_name>
    <phone>01227409501</phone>
    <email>eman18350@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Eman El-Desoki, Ph D</last_name>
    <phone>01152931418</phone>
    <email>eman18350@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>NHTMRI</name>
      <address>
        <city>Cairo</city>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eman El-Desoki, Ph D</last_name>
      <phone>01227409501</phone>
      <email>eman18350@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 3, 2018</study_first_submitted>
  <study_first_submitted_qc>March 8, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">March 12, 2018</study_first_posted>
  <last_update_submitted>March 8, 2018</last_update_submitted>
  <last_update_submitted_qc>March 8, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 12, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>National Hepatology &amp; Tropical Medicine Research Institute</investigator_affiliation>
    <investigator_full_name>Eman Desoki</investigator_full_name>
    <investigator_title>Fellow of intensive care medicine</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Critical Illness</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

